Education Speaker / Author - Marina Berenguer

Recently Added

ILTS Insights: State-of-the-Art Lecture: The Evolution of Liver Transplantation

First State-of-the-Art Lecture webinar: Sheung Tat Fan and Ronald Busuttil...

First State-of-the-Art Lecture webinar: Sheung Tat Fan and Ronald Busuttil share their insights on "The...
- Other / Multiple Topics
- Claus Niemann
- ILTS INSIGHTS
Special Topics Vanguard Webinar – Immune response to SARS-CoV-2 and De-escalation strategies

1. Immune response to SARS-CoV-2: Effect on disease course and...

1. Immune response to SARS-CoV-2: Effect on disease course and future de-escalation strategies. 2....
- COVID-19
- Gonzalo Sapisochin
- Vanguard Webinars
Special Topics Vanguard Webinar – re-opening a liver transplant program in the era of COVID-19

Topic: You are about to re-open a liver transplant program...

Topic: You are about to re-open a liver transplant program in the era of COVID-19,...
- COVID-19
- COVID-19 / Transplantation
- David Victor
- Vanguard Webinars
Special Topics Vanguard Webinar – COVID-19 and Transplantation 2

1.When do centers stop transplanting? Regulation and oversight at the...

1.When do centers stop transplanting? Regulation and oversight at the time of COVID-19 -What can...
- Anes/CCM
- Cardiorespiratory
- Albert Chan
- Vanguard Webinars
De-novo fatty liver post LT: Is this a new disease?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatology
- Surgery
- Marina Berenguer
- 2019 ILTS Toronto
The future of transplant oncology: Bridging the gap

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Marina Berenguer
- 2019 ILTS Consensus Conference
End-stage liver disease and liver transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatology
- Marina Berenguer
- 2018 ILTS Consensus Conference
Mastering Viral Infections in Liver Transplantation: Management of HCV patients before transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatology
- Surgery
- Marina Berenguer
- 2017 Joint International Congress
Working Groups for Immunosuppression Guidance: Immunosuppression Minimization Strategies

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Immunosuppression
- Avi Shaked
- 2017 Immunosuppression in Liver Transplantation - Park City
Update in LT for HCC: Impact of Immunosuppression on Hcc Recurrence after LT: With What? Or Avoid What?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Marina Berenguer
- 2016 ILTS Seoul
Retransplantation – It~s All About Selection: Are the New Anti-Virals a Game Changer in Selecting Candidates?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Other / multiple topics
- Marina Berenguer
- 2015 ILTS Chicago
DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: A Lead into Transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Marina Berenguer
- 2014 ILTS/ELITA/LICAGE London
PRACTICE GUIDELINES: Draft ILTS Guideline: Liver Transplantation for Alcoholic Liver Disease

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- General / Multiple topics
- Marina Berenguer
- 2014 ILTS/ELITA/LICAGE London
Focus on the Long-Term Outcomes in Liver Transplant Patients

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Marina Berenguer
- 2014 London Sponsored Symposia
HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: What are the Key Influences on Outcome in the Pre-DAA Era?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Marina Berenguer
- 2013 ILTS Sydney

International Liver Transplantation Society

The knowledge network for liver transplantation

Education Speaker / Author - Marina Berenguer

ILTS Insights: State-of-the-Art Lecture: The Evolution of Liver Transplantation

Special Topics Vanguard Webinar – Immune response to SARS-CoV-2 and De-escalation strategies

Special Topics Vanguard Webinar – re-opening a liver transplant program in the era of COVID-19

Special Topics Vanguard Webinar – COVID-19 and Transplantation 2

De-novo fatty liver post LT: Is this a new disease?

The future of transplant oncology: Bridging the gap

End-stage liver disease and liver transplantation

Mastering Viral Infections in Liver Transplantation: Management of HCV patients before transplantation

Working Groups for Immunosuppression Guidance: Immunosuppression Minimization Strategies

Update in LT for HCC: Impact of Immunosuppression on Hcc Recurrence after LT: With What? Or Avoid What?

Retransplantation – It~s All About Selection: Are the New Anti-Virals a Game Changer in Selecting Candidates?

DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: A Lead into Transplantation

PRACTICE GUIDELINES: Draft ILTS Guideline: Liver Transplantation for Alcoholic Liver Disease

Focus on the Long-Term Outcomes in Liver Transplant Patients

HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: What are the Key Influences on Outcome in the Pre-DAA Era?

Specialty Sections

Content Directories